Integrative network toxicology and multi-omics analyses reveal divergent molecular programs underlying pyrethroid-induced ovarian dysfunction

• Three pyrethroids converge on ovarian-reserve loss with divergent programs. • Phenotype-matched dosing separates compound effects from dose effects. • Type I/II classification does not predict ovarian molecular responses. • CDK4-centered cell-cycle remodeling occurs in compound-specific directions.